Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Veru initiates enrolment in Phase III trial of sabizabulin for Covid-19

pharmaceutical-technologyMay 20, 2021

Tag: COVID-19 , sabizabulin , Veru , ARDS

PharmaSources Customer Service